Watch a 40% Decline Disappearhttp://www.fool.com/investing/dividends-income/2010/10/19/watch-a-40-decline-disappear.aspx Brian Orelli
October 19, 2010
The greatest thing going for Johnson & Johnson (NYSE: JNJ ) is its diversity in product offerings.
Recall after recall led to U.S. sales of over-the-counter drugs and nutritional products plunging 40% in the third quarter. That would crush most companies. Johnson & Johnson? It just laughs it off.
The company sells other consumer products, so overall U.S. consumer sales were